Inspire Medical Systems, Inc. (NYSE:INSP) Shares Acquired by B. Metzler seel. Sohn & Co. AG

B. Metzler seel. Sohn & Co. AG grew its position in Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) by 46.9% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 13,425 shares of the company's stock after buying an additional 4,285 shares during the period. B. Metzler seel. Sohn & Co. AG's holdings in Inspire Medical Systems were worth $2,489,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Mutual of America Capital Management LLC increased its position in Inspire Medical Systems by 1.2% during the 4th quarter. Mutual of America Capital Management LLC now owns 4,540 shares of the company's stock valued at $842,000 after buying an additional 55 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in shares of Inspire Medical Systems by 1.0% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 7,879 shares of the company's stock valued at $1,461,000 after acquiring an additional 79 shares in the last quarter. Xponance Inc. raised its position in shares of Inspire Medical Systems by 2.2% in the 4th quarter. Xponance Inc. now owns 3,824 shares of the company's stock valued at $709,000 after purchasing an additional 82 shares during the last quarter. Harbour Investments Inc. boosted its stake in Inspire Medical Systems by 101.0% in the 4th quarter. Harbour Investments Inc. now owns 197 shares of the company's stock worth $37,000 after purchasing an additional 99 shares in the last quarter. Finally, Nisa Investment Advisors LLC grew its position in Inspire Medical Systems by 37.3% during the 4th quarter. Nisa Investment Advisors LLC now owns 368 shares of the company's stock worth $68,000 after purchasing an additional 100 shares during the last quarter. Hedge funds and other institutional investors own 94.91% of the company's stock.

Remove Ads

Inspire Medical Systems Stock Down 5.3 %

Shares of NYSE INSP traded down $7.92 during midday trading on Friday, reaching $141.49. 730,389 shares of the stock were exchanged, compared to its average volume of 589,302. The firm has a market cap of $4.21 billion, a price-to-earnings ratio of 81.78, a PEG ratio of 2.86 and a beta of 1.39. The firm has a 50-day simple moving average of $175.94 and a two-hundred day simple moving average of $188.21. Inspire Medical Systems, Inc. has a twelve month low of $123.00 and a twelve month high of $257.40.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last announced its earnings results on Monday, February 10th. The company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.74 by $0.41. Inspire Medical Systems had a net margin of 6.67% and a return on equity of 8.19%. Research analysts expect that Inspire Medical Systems, Inc. will post 2.16 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have issued reports on INSP shares. Piper Sandler decreased their price target on shares of Inspire Medical Systems from $260.00 to $233.00 and set an "overweight" rating for the company in a report on Monday, February 10th. Morgan Stanley reduced their target price on Inspire Medical Systems from $230.00 to $220.00 and set an "overweight" rating for the company in a research note on Tuesday, February 11th. Robert W. Baird dropped their price target on Inspire Medical Systems from $252.00 to $248.00 and set an "outperform" rating on the stock in a research note on Tuesday, February 11th. Royal Bank of Canada reissued an "outperform" rating and issued a $260.00 price objective on shares of Inspire Medical Systems in a report on Tuesday, February 11th. Finally, Stifel Nicolaus decreased their target price on Inspire Medical Systems from $200.00 to $190.00 and set a "hold" rating for the company in a report on Tuesday, January 21st. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, Inspire Medical Systems has a consensus rating of "Moderate Buy" and an average price target of $226.70.

Insider Activity

In related news, insider Randy Ban sold 25,584 shares of Inspire Medical Systems stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $183.50, for a total value of $4,694,664.00. Following the completion of the transaction, the insider now owns 7,259 shares in the company, valued at $1,332,026.50. The trade was a 77.90 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CTO John Rondoni sold 583 shares of the business's stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $170.49, for a total value of $99,395.67. Following the sale, the chief technology officer now owns 10,424 shares of the company's stock, valued at approximately $1,777,187.76. The trade was a 5.30 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 26,225 shares of company stock valued at $4,806,530. 4.10% of the stock is currently owned by company insiders.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.